



Leisure time physical activity and incident use of prescription tranquilizers: a 
longitudinal population-based study 
 
Mashhood Ahmed Sheikh1 
Citation: 
Sheikh, M.A., 2018. Leisure time physical activity and incident use of prescription 
tranquilizers: a longitudinal population-based study. Journal of Affective Disorders 238, 327-
335. doi: 10.1016/j.jad.2018.06.010 
  
 
Running title: Physical activity and use of tranquilizers 
 
1. Department of Community Medicine, University of Tromsø, 9037 Tromsø, Norway 
Acknowledgments: I am thankful to Brendon Stubbs and Davy Vancampfort. 
Conflict of interest: None 










Objective: Physical inactivity is a major public health problem associated with an increased 
risk of several psychiatric and physical conditions. This study investigated the association 
between leisure time physical activity (PA) and incident use of prescription tranquilizers in a 
regionally representative and prospective cohort. Methods: A total of 4043 men and women 
(mean age: 61.3 years; 57% women) from the Tromsø Study were followed for six years. 
Leisure time PA was captured at baseline. Psychiatric morbidity was measured by use of 
prescription tranquilizers, captured at both baseline and follow-up. Leisure time PA at 
baseline was used as a predictor of subsequent (incident) use of prescription tranquilizers. We 
used multinomial regression models and Poisson regression models to estimate relative risk-
ratios (RRRs), and relative risks (RRs), respectively, and their corresponding 95% confidence 
intervals (CIs). Results: In the fully-adjusted model, accounting for socio-demographic 
factors, parental history of psychopathology, years of education, smoking, respondent’s 
psychopathology at baseline, and occupational PA, a lower leisure time PA conferred a 41% 
increased risk of incident use of prescription tranquilizers at follow-up (RR= 1.41, 95% CI: 
1.09, 1.83; p=0.010). Conclusions: These findings suggest that physical inactivity increases 
the risk of psychiatric morbidity (albeit, measured via use of prescription tranquilizers). 
Future regionally representative and longitudinal research is required to confirm/refute our 
findings and explore underlying mechanisms. 









• Leisure time physical activity conferred protection against incident use of tranquilizers. 
• Lower leisure time physical activity is associated with increased incident use of 
tranquilizers six years later.   
• Physical activity in late–midlife can be important for preventing mild psychiatric morbidity 




















Previous evidence suggests that leisure time physical activity (PA) plays a protective role for 
burnout, psychological distress, depression, and anxiety (Gerber et al., 2013; Gudmundsson 
et al., 2015; Josefsson et al., 2014; Lindwall et al., 2014; Perales et al., 2014; Sheikh et al., 
2018; Teychenne et al., 2008). However, a paucity of regionally representative, prospective 
studies have assessed the association between leisure time PA and psychiatric morbidity 
(Sheikh et al., 2018).  
The Tromsø Study is a longitudinal population-based study of the general population, 
representative of adults in corresponding age groups in the Tromsø region, Norway (Jacobsen 
et al., 2012). Although no validated instruments for psychiatric diagnosis were included in the 
surveys, questions on use of prescription medication were included. Psychotropic medication, 
such as tranquilizers and sedatives, are prescribed for several psychopathologies and 
psychiatric disorders, including depression, dysthymia, phobias, PTSD, anxiety disorders, 
and mood disorders (Lahti et al., 2013; Sanchez-Villegas et al., 2008; Stubbs et al., 2017; 
Waller et al., 2016). Therefore, a longitudinal association between a lower leisure time PA 
and incident use of prescription tranquilizers may suggest that a lower leisure time PA is 
associated with an increased risk of psychiatric morbidity (Sanchez-Villegas et al., 2008). 
This assumption underlies this study.  
In this study, we set out to assess the longitudinal association between leisure time PA 
and incident use of prescription tranquilizers. The influence of prior use of prescription 
tranquilizer medication and other key covariates at baseline such as age, gender, parental 
history of psychopathology, years of education, marital status, smoking, psychological 




they have been associated with psychiatric morbidity in previous studies (Lahti et al., 2013; 







The Tromsø Study is a representative, prospective cohort study of the adult population 
residing in the municipality of Tromsø, Norway (Jacobsen et al., 2012). Between 1974 and 
2007–2008, six waves of the Tromsø Study were conducted (referred to as Tromsø I–VI) 
(Jacobsen et al., 2012). The present study has a two-wave design. To be eligible for the 
present analyses, participants had to have attended both Tromsø V (2001–02) and Tromsø VI 
(2007–08) (N = 4630). The study sample included respondents aged 30–81 (mean: 61.3) at 
Tromsø V, and 36–87 (mean: 67.3) at Tromsø VI. 
 
Study variables 
Leisure time physical activity (Tromsø V) 
Measurement of self-reported leisure time PA is expected to be valid in population-based 
studies in Norway (Aires et al., 2003; Kristin B Borch et al., 2012). Leisure time PA was 
measured with a question on a four-point Likert scale: “How has your physical activity 
(sweating/out of breath) in leisure time been during this last year? Think of your weekly 
average hours/week for the year. Time spent going to work counts also as leisure time” 
(Sheikh, 2018f; Sheikh et al., 2018). The response alternatives were: “none”, “less than 1”, 
“1–2”, and “3 or more’ hours/week”. The scores were inverted, so that a higher score 
represents lower leisure time PA.  
 




Self-reported use of prescription tranquilizers is expected to be reliable and valid (Haapea et 
al., 2010; Hafferty et al., 2018; Rauma et al., 2013). Use of prescription tranquilizer 
medication was asked in the Tromsø VI (2007–08) questionnaire as: “How often have you 
used prescription tranquilizers during the last four weeks?” The response alternatives were: 
“not used” (n=4069); “less frequently than every week” (n=110); “every week, but not daily” 
(n=62), and; “daily” (n=76) (Sheikh, 2018d). Those reporting any of the last three categories 
were classified as using prescription tranquilizers (n=248).  
In order to assess the influence of leisure time PA at baseline on incident use of 
prescription tranquilizers at follow-up, and to avoid the effect of prior psychiatric morbidity 
on leisure time PA (reverse causality) and subsequent psychiatric morbidity (confounding), 
we excluded respondents that reported using prescription tranquilizers at baseline (n=182), 
had a clinically significant level (HSCL-10 score ≥ 18.5) of psychological distress (Sheikh et 
al., 2018; Strand et al., 2003) at baseline (n=211), and reported psychiatric problems (Sheikh, 
2018a, f) at baseline (n=351). In the remaining study sample of 4043 participants, there were 
111 incident users of prescription tranquilizers at follow-up (Table 1). The five-category 
variable was used for analysis with multinomial regression models, while the binary variable 
was used for analysis with Poisson regression models (see Table 4). 
 
Confounding variables (Tromsø V) 
Confounding variables derived from the baseline questionnaire (Tromsø V) included age, 
gender, parental history of psychopathology, years of education, smoking, marital status 
(single, married or registered partnership, widow/widower, divorced or separated), 
occupational PA, prevalence of psychiatric problems, psychological distress, insomnia and 




Wastila, 2000; The ESEMeD Mhedea investigators et al., 2004), and psychological distress 
(Myhrene Steffenak et al., 2012) are positively associated with use of prescription 
tranquilizers; while education (The ESEMeD Mhedea investigators et al., 2004) is negatively 
associated with use of prescription tranquilizers. Other studies have shown that age is 
negatively associated with leisure time PA (Sheikh et al., 2018). A higher proportion of 
women use prescription tranquilizers than men (Myhrene Steffenak et al., 2012; Norris et al., 
2011; Ohayon et al., 1998; Quintana et al., 2013; The ESEMeD Mhedea investigators et al., 
2004). Numerous studies have shown that smoking is associated with leisure time PA 
(Laaksonen et al., 2001; Løchen and Rasmussen, 1992; Morseth et al., 2016; Sheikh et al., 
2018) and mental health outcomes (Ekblad et al., 2011; Hansen and Jacobsen, 1989; Sheikh 
et al., 2018). Similarly, several studies have shown that education is positively associated 
with leisure time PA (Morseth et al., 2016; Seiluri et al., 2011; Sheikh et al., 2018) and 
negatively associated with a wide range of mental health outcomes (Sheikh, 2018b; Sheikh et 
al., 2018).  
Valid information on age and gender was obtained from Statistics Norway, using the 
unique personal identification number of each respondent. Mother's/father's history of 
psychopathology was measured as: “Does your mother/father have/has your mother/father 
ever had psychiatric problems?” (yes, no). The test-retest reliability of mother's history 
of psychopathology and father's history of psychopathology in the Tromsø Study were 
Kappa: 0.57 (95% CI: 0.52–0.62) and Kappa: 0.61 (95% CI: 0.53–0.69), respectively 
(Sheikh, 2018c). Participants reported years of education in Tromsø V (mean = 10.50, 95% 
CI: 10.39, 10.61). The test-retest reliability of self-reported education was very good (Kappa: 
0.91, 95% CI: 0.91, 0.92) in the Tromsø Study (Sheikh, 2018e). Smoking was measured by 
the question, “Do you smoke?” (yes, daily /yes, sometimes/no, never). Occupational PA was 




work?”. The response alternatives were 1=Mostly sedentary work (e.g. office work, 
mounting); 2=Work that requires a lot of walking (e.g. shop assistant, light industrial work, 
teaching); 3=Work that requires a lot of walking and lifting (e.g. Postman, nursing, 
construction); and, 4=Heavy manual labour (e.g. forestry, heavy farm-work, heavy 
construction). The test-retest reliability of occupational PA was good in this sample 
[weighted Kappa coefficient (κ=0.74, 95% CI: 0.71-0.75); Polychoric correlation coefficient 
(ρ=0.82, p<0.001)]. Prevalence of psychiatric problems at baseline was measured by the 
question: “Do you have, or have you had psychiatric problems for which you sought help?” 
(0=no, 1=yes) (Sheikh, 2018f). Psychological distress was measured using the 10-item 
Hopkins Symptom Checklist (HSCL-10), which has been shown to have an acceptable 
degree of internal consistency in the Tromsø Study (Cronbach’s alpha: 0.90, mean inter-item 
correlation: 0.42, McDonald’s omega coefficient for composite reliability: 0.91) (Sheikh, 
2018d). The 10 items in the HSCL-10 are rated by the respondent on a four-point scale, 
ranging from not at all (1) to extremely (4) (Sheikh, 2018d). A HSCL-10 score was 
calculated by summing the score of all 10 items, thus possible scores ranged from 10 to 40, 
with 40 representing the highest and 10 representing the lowest psychological distress (mean: 
12.67, SD: 3.29). Insomnia was measured by the question: “How often do you suffer from 
sleeplessness?” (1=never, or just a few times a year, 2=1-3 times a month, 3=approximately 
once a week, 4=more than once a month) (Sheikh, 2018d). Use of prescription tranquilizer 
medication was also asked in the Tromsø V (2001-02) questionnaire as: “How often have you 
used prescription tranquilizers during the last four weeks?” The response alternatives were: 






This investigation was carried out in accordance with the latest version of the Declaration of 
Helsinki. The Tromsø Study has been approved by the Regional Committee for Medical and 
Health Research Ethics, the Data Inspectorate, and the Norwegian Directorate of Health. 
Written informed consent was obtained from all individual participants included in the study. 
 
Statistical analysis 
All analyses were conducted using Stata version 15 (StataCorp LLC). Baseline characteristics 
of the study sample were determined with means (standard error), and proportions (Table 1). 
Missing values were generated with multiple imputation with chained equations. A 
comparison between the complete-case (excluding missing) and the imputed dataset is 
presented with proportions (%), and mean (standard error) (Table 1). Concordance between 
use of prescription tranquilizers at baseline (Tromsø V), and follow-up (Tromsø VI) was 
assessed with Kappa statistic (κ) (Sheikh et al., 2016) and Polychoric correlation (ρ) 
(Kolenikov and Angeles, 2004). Established benchmarks for rating the strength of Kappa 
concordance as poor (<0.20), fair (>0.20 to ⩽0.40), moderate (>0.40 to ⩽0.60), good (>0.60 
to ⩽0.80), and very good (>0.80 to ⩽1.00) were used (Sheikh et al., 2016). We estimated 
Pearson product-moment correlations between all binary, ordinal or continuous variables in 
this study (Table 2). 
We assessed the association between all covariates and prevalent use of prescription 
tranquilizers at follow-up (binary variable) with Poisson regression models (Table 3). 
Relative risks (RRs) were estimated, and both unadjusted (crude) and adjusted estimates from 
multivariable regression model are presented (Table 3). Leisure time PA was modelled as a 
continuous variable in the regression analysis. To assess the linear trend of association 




modelled as a continuous variable. No statistically significant multiplicative interactions 
between leisure time PA and confounding variables were observed. Error variance was 
derived with first-order Taylor-series linearization method (Huber, 1967; White, 1980) in 
Stata, and 95% confidence intervals (CIs) are presented.   
We used multinomial regression models and Poisson regression models to assess the 
association between leisure time PA and incident use of prescription tranquilizers at follow-
up (Table 4). Relative risks (RRs), and relative risk ratios (RRRs) were estimated (Table 4). 
Five-category variable of incident use of prescription tranquilizers was used as dependent 
variable in multinomial regression model (reference=not used prescription tranquilizers), 
while binary variable (0=not used, 1=used prescription tranquilizers) was utilized as the 
dependent variable in Poisson regression models (Table 4). We used an Ordinary Least 
Square regression (OLS) model to assess the linear trend of association between leisure time 
PA and frequency of incident use of prescription tranquilizers. To assess the collinearity of 
regressors, we estimated variance inflation factors (VIFs) in Stata (-vif-) (Hamilton, 2013). In 
the fully-adjusted model, mean VIF was 1.29, and none of the individual regressors’ VIF 
(binary or continuous variables) were greater than 1.33 (VIF for age and psychological 
distress). Similarly, in the complete-case analysis, we observed that fully-adjusted regression 
models (OLS and Poisson) were correctly specified (Stata command –linktest–). The –
linktest– is based on the idea that if a regression model is properly specified, one should not 
be able to find any additional independent variables that are statistically significant except by 








The distribution of variables was similar in the complete-case dataset (excluding those with 
missing values) and the imputed datasets (Table 1). Women were more likely to have missing 
value on leisure time PA (p<0.001), prevalent use of prescription tranquilizers at follow-up 
(p<0.001), and incident use of prescription tranquilizers at follow-up (p<0.001). Missing 
values on leisure time PA were associated positively with age (p<0.001), and psychological 
distress (p=0.007); while years of education (p<0.001) were associated negatively. A higher 
age (p<0.001), father’s history of psychopathology (p=0.027), being single (p=0.023), and a 
lower education (p=0.001) were associated with missing values on prevalent use of 
prescription tranquilizers at follow-up. Similarly, a higher age (p<0.001), father’s history of 
psychopathology (p=0.019), a higher psychological distress (p=0.015), being single 
(p=0.019), and a lower education (p=0.004) were associated with missing values on incident 
use of prescription tranquilizers at follow-up. 
The concordance of use of prescription tranquilizers between Tromsø V (2001–02) 
and Tromsø VI (2007–08) was moderate [Kappa coefficient (κ=0.48, 95% CI: 0.42, 0.54); 
weighted Kappa coefficient (κ=0.46, 95% CI: 0.36, 0.50); Pearson’s correlation (r=0.47, 
p<0.001) (Table 2); Polychoric correlation (ρ=0.78, p<0.001)]. A higher age and female 
gender were associated (p<0.001) with a lower leisure time PA in MI dataset (Table 2). 
Similarly, in the complete-case analysis, women reported lower leisure time PA than men [t 
(3720) =11.58, p < 0.001]. A lower education level and a lower occupational PA were 
Ą  Ą  Ķ혵 Ć 혯 
PA was associated (p<0.001) with a higher psychological distress and insomnia at baseline 
(Table 2). A higher age (p<0.001), female gender (p<0.001), mother’s history of 
psychopathology (p<0.01), and a lower education (p<0.001) were associated with prevalent 




baseline, a higher psychological distress, and insomnia were associated (p<0.001) with 
prevalent use of prescription tranquilizers at baseline, and follow-up (Table 2). Moreover, a 
lower leisure time PA was associated with prevalent use of prescription tranquilizers at 
baseline, and follow-up (Table 2).  
 
Association between covariates (at baseline) and prevalent use of prescription 
tranquilizers at follow-up 
Two estimates are presented in Table 3 for each covariate: crude (unadjusted), and estimates 
adjusted for all other covariates. In the fully-adjusted model, a higher age (RR=1.02, 95% CI: 
1.01, 1.04; p=0.003), mother’s history of psychopathology (RR=1.35, p=0.079), a lower 
education (RR=0.93, 95% CI: 0.90, 0.97; p=0.001), daily smoking (reference=never 
smoking) (RR=1.26, p=0.081), psychiatric problems at baseline (RR=1.93, 95% CI: 1.38, 
2.71; p<0.001), insomnia at baseline (p for linear trend=0.042), a lower leisure time PA 
(RR=1.19, 95% CI: 1.04, 1.35; p=0.010), and use of prescription tranquilizers at baseline 
(p<0.001) were associated with prevalent use of prescription tranquilizers at follow-up (Table 
3).  
 
Association between leisure time PA and incident use of prescription tranquilizers 
When incident use of prescription tranquilizers at follow-up was modelled as a continuous 
variable (i.e., without collapsing into a binary variable) in an OLS regression model, the test 
for linear trend for the estimate of leisure time PA was statistically significant, but the 
estimate was close to null (βPA = 0.01, p=0.038). Consequently, when a multinomial 
regression model was used to assess the association between leisure time PA and incident use 




expected direction (Table 4). With no incident prescription tranquilizer use as the reference 
(n=3658) in the fully-adjusted multinomial regression model, a lower leisure time PA was 
associated with 60% increased risk of using prescription tranquilizers less frequently than 
every week (RRR=1.60, 95% CI: 1.12, 2.28; p=0.010); a 14% increased risk of using 
prescription tranquilizers every week, but not daily (RRR=1.14, 95% CI: 0.63, 2.06; 
p=0.667); and a 47% increased risk of using prescription tranquilizers daily (RRR=1.47, 95% 
CI: 0.82, 2.65; p=0.192) (Table 4). This trend may suggest that leisure time PA is most 
effective for mild psychiatric morbidity [reflected by category incident use of prescription 
tranquilizers less frequently than every week]. Moreover, when binary variable was used as 
an outcome, a lower leisure time PA conferred a 41% increased risk of incident use of 














Our objective was to examine the relationship between leisure time PA and subsequent 
psychiatric morbidity, measured via use of prescription tranquilizers in a regionally 
representative, prospective cohort in Norway. To the best of our knowledge, the current study 
is the first to explore the longitudinal relation between leisure time PA and use of prescription 
tranquilizers. In summary, our results suggest that leisure time physical activity conferred 
protection against incident use of prescription tranquilizers. Although the point estimates of 
the RRRs went in a similar direction, statistically non-significant differences were observed 
for frequent (incident) use of prescription tranquilizer at follow-up. A lower leisure time PA 
was not significantly associated with severity of psychiatric morbidity (expressed via frequent 
incident use of prescription tranquilizers). We observed weaker and statistically non-
significant associations among more frequent than every week incident users of prescription 
tranquilizers at follow-up, compared to non-users. The lowest RRR was seen among every 
week, but not daily incident users of prescription tranquilizers at follow-up in fully-adjusted 
model. However, the association was strongest when the analysis included the respondents 
who only used prescription (incident) tranquilizers “less frequently than every week”. This 
pattern of findings indicate that physical inactivity is significantly associated with less severe 
psychiatric morbidity, as expressed by ‘less frequently than every week’ use of prescription 
tranquilizers, but not with more severe psychiatric morbidity, as implied by a need for more 
frequent use of prescription tranquilizers. Other studies have also found a similar trend 
(Teychenne et al., 2008; Waller et al., 2016).  
Consistent with previous studies, age (Simoni-Wastila, 2000; The ESEMeD Mhedea 
investigators et al., 2004) was positively associated with use of prescription tranquilizers. 
Similarly, consistent with previous studies (Kim et al., 2008), occupational PA was not 




from Finland in which leisure time PA was associated with decreased risk for using 
psychotropic medications (Lahti et al., 2013; Stubbs et al., 2017). However, our study used 
specific data on the use of prescription tranquilizers only. To our knowledge, no longitudinal 
studies on the association between leisure time PA and use of prescription tranquilizers 
(alone) have been conducted.  
The results of this study suggest that leisure time PA in late–midlife may be important 
in the prevention of relatively mild psychiatric morbidity in early old age. One possibility is 
that psychopathology at baseline mediates the association between leisure time PA at baseline 
and incident psychiatric morbidity at follow-up (expressed via incident use of prescription 
tranquilizers). We explored this mediation mechanism, and the indirect effect was statistically 
significant (p=0.045; data not shown). However, since leisure time PA and indicators of 
psychopathology at baseline were measured at the same point in time, the temporality 
between them cannot be ascertained in this study.  
Several potential mechanisms may explain the association between PA and 
psychiatric morbidity (Ma, 2008). PA increases several neurotransmitters, such as serotonin, 
dopamine, glutamate, and acetylcholine, which may protect against depression and other 
mood disorders (Deslandes et al., 2009; Szuhany et al., 2015). Given the established links 
between both psychological well-being (Goldman-Mellor et al., 2010; Wium-Andersen et al., 
2013), mood disorders (Kohler et al., 2017) and PA (Gleeson et al., 2011) with inflammatory 
pathways (Vogelzangs et al., 2012), it is plausible to hypothesize that a better mental health 
experienced by physically active individuals might be partly explained by underlying 
inflammatory mechanisms, in particular a c-reactive protein pathway (Johnson et al., 2013; 
Vogelzangs et al., 2012). Moreover, recent advances in exercise neuroscience using rodent 
models (Duman et al., 2008; Fulk et al., 2004; Greenwood et al., 2012; Sciolino and Holmes, 




adaptations in brain circuits implicated in stress-related disorders (Holmes, 2014). This 
literature reveals that the most significant impact of PA on stress may not pertain to 
regulating transient states occurring in the presence of the stressor, but rather on moderating 
the long-term impact that acute stress may incur on subsequent stress events (Holmes, 2014). 
Much work has already demonstrated the capacity for PA to induce a variety of trophic 
factors in the brain and periphery, such as brain-derived neurotrophic factor (BDNF) 
(Szuhany et al., 2015), insulin-like growth factor, and vascular endothelial growth factor, but 
most of this previous research has focused on BDNF signaling in the hippocampus (Brown et 
al., 2014; Holmes, 2014; Ma, 2008; Voss et al., 2013). There is also evidence to suggest that 
the pro-inflammatory cytokines impair some of the growth factor signaling pathways in the 
brain, thus anti-inflammatory actions of exercise may again be important (Cotman and 
Berchtold, 2007; Cotman et al., 2007; Knaepen et al., 2010).  
To the extent that use of prescription tranquilizers serves as a surrogate marker for 
underlying psychiatric morbidity (Sanchez-Villegas et al., 2008), these findings are consistent 
with the reported association of leisure time PA and mental health (Sheikh et al., 2018). This 
is encouraging, particularly given the multiple side effects associated with use of prescription 
tranquilizers and sedatives (Correll et al., 2015; Cuerda et al., 2013; Grundy et al., 2014; 
Hulkko et al., 2017; Kelly and Pawson, 2015). The potential cardiovascular effects of 
tricyclic tranquilizers are well known (Hamer et al., 2011; Licht et al., 2009). They can cause 
orthostatic hypotension, slowed cardiac conduction, and increased heart rate, and are 
therefore best avoided in patients with pre-existing cardiovascular disease (Mago et al., 
2014). Use of tricyclic tranquilizers can also cause metabolic syndrome (Van Reedt Dortland 
et al., 2010), orthostatic hypotension, slowed cardiac conduction, increased heart rate (Mago 
et al., 2014), high diastolic and systolic blood pressures and hypertension (Licht et al., 2009). 




(modest) QTc prolongation (Beach et al., 2014). Serotonin-norepinephrine reuptake inhibitors 
(SNRIs) are associated with a small, but increased incidence of cardiovascular adverse events 
(hypertension, tachycardia and orthostatic hypotension) (Mago et al., 2014). Similarly, use of 
prescription tranquilizers is also associated with an increased risk of diabetes (Pan et al., 
2010; Rubin et al., 2008; Yoon et al., 2013). Moreover, a few studies found that use of 
prescription tranquilizers might also increase the risk of atrial fibrillation (Blanchette et al., 
2008; Cohen et al., 2000; Coupland et al., 2011; Hippisley-Cox et al., 2001; Tata et al., 
2005), hemorrhagic and fatal stroke (Smoller et al., 2009). 
It is important to highlight that the present findings should be interpreted with caution 
because of some limitations in our data. There is substantially heterogeneity in the study 
sample as it is population-based. Indeed, there may be differences between respondents via 
unaccounted-for covariates, which in turn may moderate the association between physical 
inactivity and incident use of prescription tranquilizers. However, among the measured 
covariates, no statistically significant multiplicative interactions were observed. Whilst the 
results of this study imply that leisure time PA is associated with lower risk of psychiatric 
morbidity, this study lacks specificity as information on specific psychopathologies and 
psychiatric disorders was not measured in the questionnaire. Indeed, the use of prescription 
tranquilizers may not be considered as a direct measure of psychiatric morbidity. 
Tranquilizers are mostly prescribed for depressive disorders, but they are also used to treat 
anxiety disorders, obsessive-compulsive disorders, and pain disorders. Accordingly, this 
study does not provide evidence on the association of leisure time PA with any specific 
psychopathology or psychiatric disorder. Moreover, we were not able to explore differences 
between the different tranquilizer medication classes (including tricyclic or 
tetracyclic tranquilizers; selective serotonin reuptake inhibitors, and serotonin norepinephrine 




medications were not measured in the questionnaire, which raises the concern that 
respondents may not have understood the question in same manner. Indeed, this raises the 
concern that the association between physical inactivity and incident use of prescription 
tranquilizers may be driven by measurement error. Another limitation of this study was that 
apolipoprotein E (ApoE) haplotypes and genotypes were not measured and controlled-for in 
this study. For instance, previous evidence suggests that the association between physical 
inactivity and dementia is more pronounced among ApoE-epsilon4 (ApoE-ε4) carriers than 
non-carriers (Rovio et al., 2005). This effect may be due to inefficient neural repair 
mechanisms in ApoE-ε4 carriers, which render them more dependent on lifestyle-related 
factors to protect against dementia. Indeed, another seminal study showed that the presence 
of copies of ApoE-ε4 leads to cumulative decreased participation in physical activities for 
patients with Alzheimer's dementia (Oliveira Fabricio et al., 2014). A further limitation of the 
study is that we did not have information about diagnoses of psychiatric disorders at baseline, 
and therefore these individuals could not be excluded from the study. However, we had 
information about use of prescription tranquilizers at baseline, clinically significant 
psychological distress at baseline, and self-reported psychiatric problems at baseline, and we 
were able to exclude all of these respondents from the analyses. The concordance between 
use of prescription tranquilizers at Tromsø V and Tromsø VI was moderate, which suggests 
both possibilities that (i) a substantial number of cases may have recovered from psychiatric 
morbidity; and (ii) a substantial number of new cases may have emerged over the course of 
six years, as reflected in number of incident users (n=111) of prescription tranquilizers in this 
study. 
All variables, except age and gender are self-reported; therefore, the possibility of 
reporting errors cannot be ruled out (Sheikh, 2018d). Leisure time PA was measured with a 




error, which would lead to under-estimation of its association with use of prescription 
tranquilizers. Simple questions measuring leisure time PA are generally accepted as adequate 
in population-based surveys (Westerterp, 2009). Moreover, no single instrument for 
measurement of self-reported leisure time PA has been proven as better than the others (van 
Poppel et al., 2010). Other evidence from Norway suggests that measurement of self-reported 
leisure time PA in population-based surveys is valid (Kristin B Borch et al., 2012). Lastly, the 
association between physical inactivity and psychiatric morbidity is likely to be reciprocal 
(Stubbs et al., 2017) and in our study, we only examined the physical inactivity to psychiatric 
morbidity pathway. 
The current study has a number of strengths. We utilized a prospective design, and a 
regionally representative sample of general population in Norway. One previous study 
(Stubbs et al., 2017) did not adjust for prevalent psychopathology at baseline. A longitudinal 
association between leisure time PA and psychiatric morbidity is likely confounded by 
respondent’s psychopathology at the time of reporting leisure time PA (Sheikh et al., 2018). 
Indeed, without controlling for psychopathology at baseline, either by adjustment or by 
removal of prevalent cases from the analysis, the longitudinal association between leisure 
time PA and psychiatric morbidity remains questionable (Sheikh et al., 2018). Moreover, 
other studies (Lahti et al., 2013; Sanchez-Villegas et al., 2008; Stubbs et al., 2017; Waller et 
al., 2016) did not account for occupational PA in the analysis. Leisure time PA comprises 
only a fraction of total daily/weekly PA, and without controlling for occupational PA, the 
association between leisure time PA and psychiatric morbidity (measured via use of 
prescription tranquilizers) is likely to be over-estimated (Sheikh et al., 2018). In this study, 
we were able to control for a wide range of important confounding variables including 
parental history of psychopathology, occupational PA, and respondent’s psychopathology at 




We examined the longitudinal relationship between leisure time PA and use of 
prescription tranquilizers and found that a lower leisure time PA is associated with an 
incident use of prescription tranquilizers after adjusting for pertinent confounding variables. 
Given these findings, our data suggest that leisure time PA has an important role in 
maintaining psychological well-being (Sheikh et al., 2018) and reducing the need for 
prescription tranquilizers. Promoting leisure time PA in adulthood may prove useful for 
preventing subsequent mild psychiatric morbidity. We conclude that leisure time PA in late–






























































































































































































































































































 Complete-case data Imputed data 
 Mean (SE) n (%) Mean (SE) % 
Age  61.25 (0.15) - -b - 
Gender Male - 1896 (40.9) - -b 
 Female - 2734 (59.1) - -b 
History of psychopathology, mother Yes - 273 (5.9) - -b 
History of psychopathology, father Yes - 117 (2.5) - -b 
Years of education 10.53 (0.06) - 10.50 (0.06) - 
Smoking a Never smoker - 2986 (69.9) - 69.9 
 Occasional smoker - 282 (6.6) - 6.6 
 Daily smoker - 1003 (23.5) - 23.5 
Marital status a Single - 433 (9.4) - 9.4 
 Married or registered partnership - 3149 (68.0) - 68.0 
 Widowed, divorced or separated - 1046 (22.6) - 22.6 
Occupational physical activity a 1.81 (0.02) - 1.81 (0.02) - 
 Mostly sedentary work - 1265 (47.2) - 47.0 
 Work that requires a lot of walking - 783 (29.2) - 29.1 
 Work that requires a lot of walking and lifting - 513 (19.1) - 19.3 
 Heavy manual labour - 121 (4.5) - 4.6 
Psychiatric problems Yes - 351 (7.8) - 7.9 
Psychological distress (HSCL-10) 12.22 (0.05) - 12.67 (0.06) - 
Insomnia a 1.58 (0.02) - 1.58 (0.02) - 
 Never, or just a few times a year - 2955 (70.2) - 70.1 
 1-3 times a month - 556 (13.2) - 13.2 
 Approximately once a week - 215 (5.1) - 5.1 
 More than once a week - 484 (11.5) - 11.6 
Leisure time physical activity (hours/week) a 2.11 (0.02) - 2.09 (0.02) - 
 None - 1306 (35.1) - 36.0 
 Less than 1 - 1095 (29.4) - 29.4 
 1-2 - 923 (24.8) - 24.4 
 3 or more - 398 (10.7) - 10.3 
Use of prescription tranquilizers at baseline (Tromsø V) a 1.08 (0.01) - 1.09 (0.01) - 
 Not used - 3874 (95.5) - 95.1 
 Less frequently than every week - 85 (2.1) - 2.2 




 Daily - 49 (1.2) - 1.4 
Prevalent use of prescription tranquilizers at follow-up (Tromsø VI) a 1.11 (0.01) - 1.11 (0.01) - 
 Not used - 4069 (94.3) - 93.9 
 Less frequently than every week - 110 (2.6) - 2.7 
 Every week, but not daily - 62 (1.4) - 1.5 
 Daily - 76 (1.8) - 1.9 
Incident use of prescription tranquilizers at follow-up (Tromsø VI) c 1.05 (0.01) - 1.06 (0.01) - 
 Not used - 3658 (97.1) - 96.8 
 Less frequently than every week - 62 (1.6) - 1.7 
 Every week, but not daily - 22 (0.6) - 0.7 
 Daily - 27 (0.7) - 0.8 
a The numbers for some variables do not add up to 4630 due to missing values. 
b There were no missing values, so no imputations were made for these variables. 
c The numbers do not add up to 4043 due to missing values. 




















Table 2. Bivariate Pearson product-moment correlations between variables (n=4630) 
 
 1 2 3 4 5 6 7 8 9 10 11 12
 r r r r r r r r r r r r
1. Age 1.00  
2. Gender 0.02 1.00  
3. History of psychopathology, mother -0.07 d -0.03 a 1.00  
4. History of psychopathology, father -0.08 d -0.01 0.02 1.00  
5. Years of education -0.39 d 0.03 b 0.04 c 0.07 d 1.00
6. Occupational physical activity 0.01 0.02 a 0.01 -0.02 -0.22 d 1.00
7. Psychiatric problems -0.02 -0.08 d 0.13 d 0.06 d 0.04 c -0.02 b 1.00
8. Psychological distress (HSCL-10) 0.01 c -0.18 d 0.10 d 0.02 -0.07 0.02 0.33 d 1.00
9. Insomnia 0.11 d -0.19 d 0.06 d -0.01 -0.08 d -0.03 b 0.14 d 0.43 d 1.00
10. Leisure time physical activity 0.11 d -0.19 d -0.03 b 0.01 -0.13 d -0.11 d -0.01 0.07 d 0.09 d 1.00
11. Use of prescription tranquilizers (baseline) 0.08 d -0.07 d 0.03 a -0.01 -0.08 d -0.01 a 0.29 d 0.31 d 0.18 d 0.06 d 1.00










Table 3. Association between covariates and prevalent use of prescription tranquilizers at follow-up (N=4630). 1 
 2 
 Prevalent use of prescription tranquilizers g
 Unadjusted Adjustede
 RR (95% CI) RR (95% CI)
Age f 1.05 (1.03, 1.06)d 1.02 (1.01, 1.04)c
Gender f Male (reference=female) 0.48 (0.36, 0.63)d 0.82 (0.62, 1.08)
History of psychopathology, mother f Yes (reference=no) 1.82 (1.26, 2.64)c 1.35 (0.97, 1.90)a
History of psychopathology, father f Yes (reference=no) 1.73 (0.99, 3.05)a 1.61 (0.85, 3.02)
Years of education f 0.87 (0.84, 0.90)d 0.93 (0.90, 0.97)d
Smoking f Never smoker 1.00 1.00
 Occasional smoker 1.40 (1.09, 1.81)c 1.26 (0.97, 1.63)a
 Daily smoker 0.87 (0.51, 1.50) 1.12 (0.67, 1.87)
Marital status f Single 1.00 1.00
 Married or registered partnership 1.38 (0.84, 2.26) 1.00 (0.65, 1.54)
 Widowed, divorced or separated 2.14 (1.28, 3.58)c 1.11 (0.70, 1.77)
Occupational physical activity f 0.95 (0.78, 1.15) 0.94 (0.81, 1.10)
Psychiatric problems f Yes (reference=no) 5.89 (4.67, 7.42)d 1.93 (1.38, 2.71)d
Psychological distress (HSCL-10) f 1.14 (1.13, 1.16)d 1.01 (0.99, 1.04)
Insomnia f Never, or just a few times a year (reference) 1.00 1.00
 1-3 times a month 2.20 (1.56, 3.10)d 1.44 (1.03, 2.00)b
 Approximately once a week 3.35 (2.22, 5.05)d 1.39 (0.89, 2.18)
 More than once a week 3.94 (2.99, 5.18)d 1.40 (1.00, 1.95)a
Leisure time physical activity (hours/week) f 1.46 (1.24, 1.71)d 1.19 (1.04, 1.35)c
Use of prescription tranquilizers at baseline (Tromsø V) f Not used (reference) 1.00 1.00
 Less frequently than every week 14.52 (10.93, 19.29)d 8.17 (5.70, 11.70)d
 Every week, but not daily 19.85 (15.25, 25.84)d 8.76 (5.76, 13.32)d





e mutually adjusted for all covariates 7 
f Covariates were measured in 2001-02 (Tromsø V) 8 
g Prevalent use of prescription tranquilizers was measured in 2007-08 (Tromsø VI) 9 








Table 4. Association between leisure time physical activity and incident use of prescription tranquilizers at follow-up (N=4043). 14 
 Incident use of prescription tranquilizers f
 Not used less frequently than every week Every week, but not daily Daily
 (n=3658) (n=62) (n=22) (n=27)
 RRR (95% CI) RRR (95% CI) RRR (95% CI) RRR (95% CI)
 Unadjusted 1.00 (reference) 1.83 (1.31, 2.55) c 1.54 (0.84, 2.84) 1.79 (1.02, 3.14) a
Leisure time physical activity (hours/week) e Adjusted d 1.00 (reference) 1.60 (1.12, 2.28) b 1.14 (0.63, 2.06) 1.47 (0.82, 2.65)
 Not used Used
 (n=3658) (n=111)
 RR (95% CI) RR (95% CI)
 Unadjusted 1.00 (reference) 1.72 (1.31, 2.25) c




d Adjusted for age, gender, parental history of psychopathology, years of education, smoking, marital status, occupational PA, psychological distress and insomnia. 18 
e Leisure time PA were measured in 2001-02 (Tromsø V) 19 
f Incident use of prescription tranquilizers was measured in 2007-08 (Tromsø VI) 20 
RRR: relative risk ratio; RR: relative risk; CI: confidence interval. 21 
 22 
